Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms
暂无分享，去创建一个
A. Jankowska | C. O'keefe | J. Maciejewski | Y. Saunthararajah | Y. Sugimoto | S. Saad | A. Advani | M. Sekeres | M. Kalaycio | P. Elson | H. Makishima | F. Traina | V. Visconte | E. Copelan | R. Tiu | H. Szpurka | E. Hasrouni | A. Tabarroki | Edy Hasrouni